Y-mAbs Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 29 U.S.-traded ETFs. YMAB has around 1.3M shares in the U.S. ETF market. The largest ETF holder of YMAB is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 373.79K shares. Investors may also find of interest that the ETF with the largest allocation to YMAB stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 4.14%. On average, U.S. ETFs allocate 0.25% of YMAB to their portfolios.
Additionally, YMAB is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with YMAB as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.